New PEGylated Polylysine dendrimers: Benefits patients with cancer, HIV and lymphatic conditions (News-Medical-Net)

15 Mar 2010

Monash Institute of Pharmaceutical Science researchers, in collaboration with the biotechnology company Starpharma Holdings Ltd have developed a new method to deliver medications that may benefit thousands of patients with particular types of cancer, HIV and lymphatic conditions world-wide.

View original here:
New PEGylated Polylysine dendrimers: Benefits patients with cancer, HIV and lymphatic conditions (News-Medical-Net)

Tags: deliver-medications, film-industry, from-the, have-developed, hire-more, particular-types, patients-with, pharmaceutical, session

Comment Form

Entries (RSS)
Comments (RSS)

About Biolexis

Biolexis is a premiere online resource for life sciences professionals, investors and entrepreneurs. The site offers personalized information biotechnology news and other biotechnology resources. Information is further organized by industry sector, therapeutic areas, technology focus, service orientation, and location. With Biolexis, you can: access over 5,000 biotechnology news strories and biotechnology articles. Search biotech company information, biotech news, biotech articles and biotech related press releases.